Study on Single Administration and Dose Increment of Recombinant Human Serum Albumin/Erythrocyte Fusion Protein for Injection
Clinical trial NCT03786289 · COMPLETED
Trial details
- NCT number
- NCT03786289
- Sponsor
- Tianjin SinoBiotech Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-03
- Primary completion
- 2019-07-03
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.